Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine

NCT00514059 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

83

Enrollment

OTHER_GOV

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Polio

Interventions

DRUG: Boostrix polio

Sponsor

Norwegian Institute of Public Health